Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection

Int Rev Neurobiol. 2011:100:85-106. doi: 10.1016/B978-0-12-386467-3.00005-4.

Abstract

In Parkinson's disease, type B monoamine oxidase (MAO-B) is proposed to play an important role in the pathogenesis through production of reactive oxygen species and neurotoxins from protoxicants, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. In addition, inhibitors of MAO-B protect neurons in the cellular and animal models of Parkinson's and Alzheimer's diseases. However, the role of type A MAO (MAO-A) in neuronal death and neuroprotection by MAO-B inhibitors has been scarcely elucidated. This chapter presents our recent results on the involvement of MAO-A in the activation of mitochondrial death signal pathway and in the induction of prosurvival genes to prevent cell death with MAO-B inhibitors. The roles of MAO-A in the regulation of neuronal survival and death are discussed in concern to find a novel strategy to protect neurons in age-associated neurodegenerative disorders and depression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cell Survival / physiology*
  • Humans
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase / physiology*
  • Monoamine Oxidase / therapeutic use*
  • Monoamine Oxidase Inhibitors / pharmacology
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / enzymology*
  • Neurodegenerative Diseases / pathology*
  • Neuroprotective Agents / antagonists & inhibitors
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use*

Substances

  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents
  • Monoamine Oxidase